Effectiveness and tolerability of Perampanel in children, adolescents and young adults with refractory epilepsy: A UK national multicentre study.

@article{Swiderska2017EffectivenessAT,
  title={Effectiveness and tolerability of Perampanel in children, adolescents and young adults with refractory epilepsy: A UK national multicentre study.},
  author={Nina Swiderska and Hui Jeen Tan and Azita Rajai and Arpana Silwal and Archana Desurkar and Timorthy Martland},
  journal={Seizure},
  year={2017},
  volume={52},
  pages={
          63-70
        }
}
PURPOSE Perampanel is one of the latest antiepileptic drugs (AEDs) approved for the treatment of focal and generalised epilepsy in individuals with epilepsy aged 12 years and older. There is sparse data on the use of Perampanel in children under 12. We conducted a study amongst paediatric neurologists in the United Kingdom to investigate its effectiveness… CONTINUE READING